Christopher Labos, MD, CM, MSC

Opinion

On Second Thought: Making Sense of Blood Pressure Guidelines — What Happened in the 1930s Should Stay There

Author:: Christopher Labos, MD, CM, MSC

Publish date: January 6, 2025

If you have a high-risk patient, there is a big benefit to bringing that blood pressure down from 135 to 130. Whereas for a low-risk patient, it pr...

Opinion

An Epidemiologist’s Guide to Debunking Nutritional Research

Author:: Christopher Labos, MD, CM, MSC

Publish date: November 18, 2024

Like movies, not all studies are good. Some are just bad.

News

On Second Thought: Aspirin for Primary Prevention — What We Really Know

Author:: Christopher Labos, MD, CM, MSC

Publish date: November 6, 2024

Recommendations vis-à-vis aspirin have evolved at a dizzying pace.

News

Sodium vs Potassium for Lowering Blood Pressure?

Author:: Christopher Labos, MD, CM, MSC

Publish date: January 30, 2024

Nephrologist discusses benefits of reducing salt in diet and eating more potassium to reduce BP.

Opinion

Multivitamins and dementia: Untangling the COSMOS study web

Author:: Christopher Labos, MD, CM, MSC

Publish date: October 3, 2023

When you get a positive result in your research, it’s always exciting. But when a slew of studies that came before you are negative, you aren’t gro...

Opinion

Conflicting blood pressure targets: Déjà vu all over again

Author:: Christopher Labos, MD, CM, MSC

Publish date: July 13, 2023

Arguing about 140/90 mm Hg or 130/80 mm Hg is less important than acknowledging that we should be aggressive in screening for and treating hyperten...

Opinion

Is it time to stop treating high triglycerides?

Author:: Christopher Labos, MD, CM, MSC

Publish date: March 30, 2023

There may be noncardiovascular reasons to treat hypertriglyceridemia.